Home
About Us
Our Mission
Management
Board of Directors
Science Advisors
Science & Pipeline
Overview
Neuroplasticity
DMX-1001
Alcohol use disorder
Publications
Investors & Media
Media releases
News beats
For Investors
Media contact
Contact DemeRx
In Waves and War: Healing Trauma Through the Science of Neuroplasticity
changes
Press Release
November 13, 2025
View Article
Next Post
DemeRx Announces Successful Completion of Multiple Ascending Dose Clinical Trial of DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)
Previous Post
Eudēmonia Talent Portal | Deborah Mash – Dec 14, 15, 16
Menu